Truist Financial Maintains Sutro Biopharma(STRO.US) With Buy Rating
A Quick Look at Today's Ratings for Sutro Biopharma(STRO.US), With a Forecast Between $8 to $17
Sutro Biopharma Price Target Maintained With a $11.00/Share by Piper Sandler
A Quick Look at Today's Ratings for Sutro Biopharma(STRO.US), With a Forecast Between $11 to $17
Sutro Biopharma (STRO) Gets a Buy From Wedbush
Truist Financial Issues a Buy Rating on Sutro Biopharma (STRO)
Sutro Biopharma Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Sutro Biopharma, Maintains $12 Price Target
Sutro Biopharma's Promising ADC Innovations and Strategic Collaborations Justify a Buy Rating
Piper Sandler Maintains Sutro Biopharma(STRO.US) With Buy Rating, Maintains Target Price $11
A Quick Look at Today's Ratings for Sutro Biopharma(STRO.US), With a Forecast Between $12 to $17
Sutro Biopharma Price Target Maintained With a $17.00/Share by JMP Securities
A Quick Look at Today's Ratings for Sutro Biopharma(STRO.US), With a Forecast Between $5 to $17
Truist Financial Reaffirms Their Buy Rating on Sutro Biopharma (STRO)
HC Wainwright & Co. Reiterates Buy on Sutro Biopharma, Maintains $12 Price Target
Strong Buy Rating for Sutro Biopharma on Promising Clinical Data and Strategic Market Positioning
JMP Securities Maintains Sutro Biopharma(STRO.US) With Buy Rating, Maintains Target Price $17
Sutro Biopharma Price Target Cut to $15.00/Share From $18.00 by Truist Securities
Sutro Biopharma Analyst Ratings
Truist Financial Maintains Sutro Biopharma(STRO.US) With Buy Rating, Cuts Target Price to $15